Congruence Therapeutics
Develops small molecule correctors for diseases of protein misfolding
$39.5MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops small molecule correctors for diseases of protein misfolding
Develops therapies to halt fibrosis in multiple organ systems
Pitching Amplitude Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room